<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04825314</url>
  </required_header>
  <id_info>
    <org_study_id>0106462</org_study_id>
    <nct_id>NCT04825314</nct_id>
  </id_info>
  <brief_title>Noble Meta Alloy Coated Catheters in Patients With Long Term Catheterization</brief_title>
  <official_title>Noble Metal Alloy Coated Versus Silicone Foley Catheter in Patients With Long Term Catheterization: A Prospective Randomized Controlled Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Alexandria University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Alexandria University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Eighty percent of nosocomial UTI caused by indwelling urinary catheters and so known-as&#xD;
      catheter-associated UTI. CAUTI leads to multiple local and systemic derangements such as&#xD;
      suprapubic pain, dysuria, cystitis, pyelonephritis, septicemia, and even septic shock.&#xD;
&#xD;
      This study will be conducted up on 100 patients (50 per each group) with long term&#xD;
      catheterization to assess efficacy of noble metal alloy coated catheter in reducing CAUTI.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This prospective controlled randomized study conducted upon 100 patients at Alexandria&#xD;
      University hospital from 21 May 2020 to 21 December 2020. Patients enrolled will be divided&#xD;
      into two equal groups according to the urethral catheter inserted&#xD;
&#xD;
      The institutional ethics committee for research approved the study. Written informed consent&#xD;
      was obtained from all participants. In addition to taking the patients' medical history and&#xD;
      completing general and physical examinations, physicians will choose proper catheter size all&#xD;
      perform catheterization using aseptic technique according to guidelines of proper aseptic&#xD;
      catheterization. Urologist ensures comparable catheter size and amount of balloon inflation.&#xD;
&#xD;
      An aseptic non-touch technique (ANTT) must be used to obtain catheter specimen urine&#xD;
      following these steps:&#xD;
&#xD;
        -  After catheterization apply clamp 10 cm distal to meatus then after few minutes clean&#xD;
           the drainage port with alcohol and allow to dry then insert the syringe tip into the&#xD;
           drainage port.&#xD;
&#xD;
        -  Three to five ml of urine collected in sterile disposable plastic cup at day zero&#xD;
           (within 2 hours of catheterization), day ten and day twenty post catheterization.&#xD;
&#xD;
        -  The urine subjected to routine urine analysis, urine culture and sensitivity.&#xD;
&#xD;
      Appropriate statistical tests will be used to indicate the frequency and type of CAUTI as&#xD;
      well as to assess catheter tolerance in each arm, followed by a comparison to conclude the&#xD;
      results.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 21, 2020</start_date>
  <completion_date type="Anticipated">June 21, 2021</completion_date>
  <primary_completion_date type="Anticipated">May 21, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Urinary tract infection</measure>
    <time_frame>14 days</time_frame>
    <description>incidence of culture documented symotomatic urinary tract infection</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Catheter tolerance</measure>
    <time_frame>14 days</time_frame>
    <description>Catheter tolerance looks for discomfort or pain. Discomfort is an uncomfortable sensation due to the presence of a foreign object in the urethra without pain. The presence of actual pain is measured using VAS scoring system from zero to ten, so that a zero means no pain and a tenth means very severe pain.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Urinary Tract Infections</condition>
  <condition>Catheter Infection</condition>
  <condition>Catheter-Related Infections</condition>
  <condition>Infection</condition>
  <arm_group>
    <arm_group_label>Bactiguard urethral catheter</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Group A: Fifty Patients with urethral catheter using noble metal alloy coated catheter (Bactiguard AB, Stockholm ,Sweden).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Silicone Foley urethral catheter</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Group B: Fifty Patients with urethral catheter using silicone Foley catheter (Well Lead, Guangzhou, China).</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Urethral catheter</intervention_name>
    <description>All Patients will have urethral catheterization with either Noble Metal Alloy coated catheter or Silicon Foley catheter.</description>
    <arm_group_label>Bactiguard urethral catheter</arm_group_label>
    <arm_group_label>Silicone Foley urethral catheter</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        - Patient under age of 80 years old who need prolonged urethral catheterization (more than&#xD;
        2 weeks) as a method of bladder drainage.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients with current or recent symptomatic urinary tract infection.&#xD;
&#xD;
          -  Antibiotic use currently or within 7 days prior to inclusion.&#xD;
&#xD;
          -  Known hypersensitivity to latex, silver salts or hydrogel.&#xD;
&#xD;
          -  Patients with recent surgical intervention in the urinary tract.&#xD;
&#xD;
          -  Patients with anatomic or functional upper urinary tract issues (e.g reflux, stones,&#xD;
             etc.)&#xD;
&#xD;
          -  Uncontrolled DM. Patients on corticosteroid treatment. Immunosuppressed patients.&#xD;
             Patients received pelvic irradiation.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Tamer A Abou Youssif, MD</last_name>
    <phone>+201101200076</phone>
    <email>tamer.abouyoussif@alexmed.edu.eg</email>
  </overall_contact>
  <location>
    <facility>
      <name>Alexandria University Hospitals</name>
      <address>
        <city>Alexandria</city>
        <zip>21646</zip>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alaa Abdel Hady, MBBCH</last_name>
      <phone>+201223641864</phone>
      <email>medical_alaa@yahoo.com</email>
    </contact>
    <contact_backup>
      <last_name>Tamer A Abou Youssif, MD</last_name>
      <phone>+201101200076</phone>
      <email>tamer.abouyoussif@alexmed.edu.eg</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <reference>
    <citation>Aljohi AA, Hassan HE, Gupta RK. The efficacy of noble metal alloy urinary catheters in reducing catheter-associated urinary tract infection. Urol Ann. 2016 Oct-Dec;8(4):423-429. doi: 10.4103/0974-7796.192099.</citation>
    <PMID>28057985</PMID>
  </reference>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>March 28, 2021</study_first_submitted>
  <study_first_submitted_qc>March 28, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">April 1, 2021</study_first_posted>
  <last_update_submitted>April 4, 2021</last_update_submitted>
  <last_update_submitted_qc>April 4, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 8, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Alexandria University</investigator_affiliation>
    <investigator_full_name>Tamer Abou Youssif</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <keyword>catheter</keyword>
  <keyword>UTI</keyword>
  <keyword>Foley catheter</keyword>
  <keyword>Nobel Metal Alloy catheter</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infections</mesh_term>
    <mesh_term>Communicable Diseases</mesh_term>
    <mesh_term>Urinary Tract Infections</mesh_term>
    <mesh_term>Catheter-Related Infections</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

